Hydroxysafflor Yellow A Ameliorates Renal Fibrosis by Suppressing TGF-β1-Induced Epithelial-to-Mesenchymal Transition

Sorafenib Ameliorates Renal Fibrosis through Inhibition of TGF-β-Induced Epithelial-Mesenchymal Transition

(2015) Lining Jia et al.   PLoS One

Smad7 inhibits AngII-mediated hypertensive nephropathy in a mouse model of hypertension

(2014) Guan-Xian Liu et al.   CLINICAL SCIENCE

Endothelin and endothelin antagonists in chronic kidney disease

(2014) Donald E Kohan et al.   KIDNEY INTERNATIONAL

Chaihuang-Yishen Granule Inhibits Diabetic Kidney Disease in Rats through Blocking TGF-β/Smad3 Signaling

(2014) Ting Ting Zhao et al.   PLoS One

NMR Solution Structure Study of the Representative Component Hydroxysafflor Yellow A and Other Quinochalcone C-Glycosides from Carthamus tinctorius

(2013) Zi-Ming Feng et al.   JOURNAL OF NATURAL PRODUCTS

Chronic kidney disease: global dimension and perspectives

(2013) Vivekanand Jha et al.   LANCET

Activation of PPARγ is required for hydroxysafflor yellow A of Carthamus tinctorius to attenuate hepatic fibrosis induced by oxidative stress

(2013) C.Y. Wang et al.   PHYTOMEDICINE

Curcumin Inhibits Transforming Growth Factor-β1-Induced EMT via PPARγ Pathway, Not Smad Pathway in Renal Tubular Epithelial Cells

(2013) Rui Li et al.   PLoS One

Diverse Roles of TGF-β/Smads in Renal Fibrosis and Inflammation

(2012) Hui Yao Lan   International Journal of Biological Sciences

Prevalence of chronic kidney disease in China: a cross-sectional survey

(2012) Luxia Zhang et al.   LANCET

Inhibitory Effect of Safflor Yellow on Pulmonary Fibrosis

(2011) Lin Wang et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Hydroxysafflor yellow A protects against chronic carbon tetrachloride-induced liver fibrosis

(2011) Yingbo Zhang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Delayed Administration of Suramin Attenuates the Progression of Renal Fibrosis in Obstructive Nephropathy

(2011) N. Liu et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases

(2011) Jeffrey L. Barnes et al.   KIDNEY INTERNATIONAL

Cellular and molecular mechanisms of renal fibrosis

(2011) Youhua Liu   Nature Reviews Nephrology

Salvianolic acid B prevents epithelial-to-mesenchymal transition through the TGF-beta1 signal transduction pathway in vivo and in vitro

(2010) Qing-Lan Wang et al.   BMC CELL BIOLOGY

The Protective Role of Smad7 in Diabetic Kidney Disease: Mechanism and Therapeutic Potential

(2010) H. Y. Chen et al.   DIABETES

HSP72 Inhibits Smad3 Activation and Nuclear Translocation in Renal Epithelial-to-Mesenchymal Transition

(2010) Y. Zhou et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Endothelial-Myofibroblast Transition Contributes to the Early Development of Diabetic Renal Interstitial Fibrosis in Streptozotocin-Induced Diabetic Mice

(2009) Jinhua Li et al.   AMERICAN JOURNAL OF PATHOLOGY

New Insights into Epithelial-Mesenchymal Transition in Kidney Fibrosis

(2009) Y. Liu   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

In vitro anti-fibrotic activities of herbal compounds and herbs

(2009) Qin Hu et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Safflower extract: A novel renal fibrosis antagonist that functions by suppressing autocrine TGF-beta

(2008) Yu-Lin Yang et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Compound Astragalus and Salvia miltiorrhiza Extract exerts anti-fibrosis by mediating TGF-β/Smad signaling in myofibroblasts

(2008) Yan Yang et al.   JOURNAL OF ETHNOPHARMACOLOGY

Fibroblasts in Kidney Fibrosis Emerge via Endothelial-to-Mesenchymal Transition

(2008) E. M. Zeisberg et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY